ADiTx Inc (ADTX): $ADTX .06's on upcoming fireside cha...

Next 10 Prev Next

Send PM Follow Ignore

Followers	4045
Posts	152978
Boards Moderated	3
Alias Born	08/05/2009

TheFinalCD

Re: don estaban post# 621

Thursday, 02/13/2025 9:40:05 AM

Thursday, February 13, 2025 9:40:05 AM

$ADTX .06's on upcoming fireside chat PR to discuss possible Merger?

$ADTX PR to dump
"uglier than a Whoopie Goldberg Centerfold"😵‍💫🥴@rigatoni33 https://t.co/yitvPCXT42
— THE FINAL COUNTDOWN (@THIS_TIME_X) February 13, 2025

https://www.prnewswire.com/news-releases/syra-health-continues-to-secure-healthcare-training-contracts-302375936.html

Always consult an Investment Professional, my posts are my own opinions, and not for investing decisions

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ADTX News

Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2026 08:21:24 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2026 09:03:44 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2026 08:31:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:20:52 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2026 08:20:06 PM
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026 • Business Wire • 05/14/2026 12:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 08:20:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 08:35:47 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/23/2026 08:30:42 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/22/2026 04:15:21 AM
Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients • Business Wire • 04/20/2026 12:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/14/2026 12:00:13 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/11/2026 01:49:19 AM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/07/2026 08:02:58 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/03/2026 08:37:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 01:13:36 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:35:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 12:00:37 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/27/2026 09:02:12 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/24/2026 09:21:36 PM
Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer • Business Wire • 03/19/2026 12:15:00 PM
Aditxt Acquires Ignite Proteomics to Expand Precision Oncology Capabilities • IH Market News • 03/13/2026 03:36:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 12:35:24 PM
Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection • Business Wire • 03/13/2026 12:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:30:35 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent ADTX News

More ADTX News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent ADTX News

Go Ad-Free